Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Lung inflammatory injury and tissue repair (Jul 2023)
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8
Marija Trajkovic, … , Karl Bauer, Heike Heuer
Marija Trajkovic, … , Karl Bauer, Heike Heuer
Published March 1, 2007
Citation Information: J Clin Invest. 2007;117(3):627-635. https://doi.org/10.1172/JCI28253.
View: Text | PDF
Research Article Endocrinology

Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8

  • Text
  • PDF
Abstract

In humans, inactivating mutations in the gene of the thyroid hormone transporter monocarboxylate transporter 8 (MCT8; SLC16A2) lead to severe forms of psychomotor retardation combined with imbalanced thyroid hormone serum levels. The MCT8-null mice described here, however, developed without overt deficits but also exhibited distorted 3,5,3′-triiodothyronine (T3) and thyroxine (T4) serum levels, resulting in increased hepatic activity of type 1 deiodinase (D1). In the mutants’ brains, entry of T4 was not affected, but uptake of T3 was diminished. Moreover, the T4 and T3 content in the brain of MCT8-null mice was decreased, the activity of D2 was increased, and D3 activity was decreased, indicating the hypothyroid state of this tissue. In the CNS, analysis of T3 target genes revealed that in the mutants, the neuronal T3 uptake was impaired in an area-specific manner, with strongly elevated thyrotropin-releasing hormone transcript levels in the hypothalamic paraventricular nucleus and slightly decreased RC3 mRNA expression in striatal neurons; however, cerebellar Purkinje cells appeared unaffected, since they did not exhibit dendritic outgrowth defects and responded normally to T3 treatment in vitro. In conclusion, the circulating thyroid hormone levels of MCT8-null mice closely resemble those of humans with MCT8 mutations, yet in the mice, CNS development is only partially affected.

Authors

Marija Trajkovic, Theo J. Visser, Jens Mittag, Sigrun Horn, Jan Lukas, Veerle M. Darras, Genadij Raivich, Karl Bauer, Heike Heuer

×

Figure 3

Analysis of D1 expression in the liver of MCT8-null and wild-type animals.

Options: View larger image (or click on image) Download as PowerPoint
Analysis of D1 expression in the liver of MCT8-null and wild-type animal...
(A) D1 enzymatic activity was determined in liver and kidney preparations from 21-day-old MCT8-null mice and wild-type littermates. (B) ISH analysis of hepatic MCT8 and D1 expression in wild-type mice and D1 expression in MCT8-null animals. In MCT8-null mice, expression of D1 in liver was highly upregulated compared with the expression of D1 in liver of control animals. Expression of MCT8 in wild-type animals is shown in the lower panel. Scale bar: 450 μm. (C) Hepatic D1 and GPD2 mRNA levels were determined in 21-day-old MCT8-null mice, wild-type littermates, and athyroid Pax8–/– mice by real-time PCR. Bars in A and C represent the mean ± SEM of values obtained in each group. *P < 0.05; **P < 0.0001. (D) Transcript levels of putative hepatic thyroid hormone transporters were examined in the liver of MCT8-null mice and controls by real-time PCR. This analysis revealed no statistical differences in the expression levels for the organic anion transporting polypeptides OATP1A1, OATP1A4, and OATP1B2 and the Na+/taurocholate-cotransporting polypeptide NTCP between the different genotypes.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts